The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zaĭdieva Ia.Z.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Hyperandrogenism in postmenopausal women: clinical forms and differential diagnosis

Authors:

Zaĭdieva Ia.Z.

More about the authors

Read: 26397 times


To cite this article:

Zaĭdieva IaZ. Hyperandrogenism in postmenopausal women: clinical forms and differential diagnosis. Russian Bulletin of Obstetrician-Gynecologist. 2013;13(4):89‑94. (In Russ.)

Recommended articles:
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114

References:

  1. Azziz R., Sanchez L.A., Knochenhauer E.S., Moran C., Lazenby J., Stephens K.C., Taylor K. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metabol 2004; 89: 453-462.
  2. Azziz R., Carmina E., Dewailly D., Ehrmann D., Legro R.S., Reyna R. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metabol 2006; 91: 4237-4245.
  3. Brown D.L., Henrichsen T.L., Clayton A.C., Hudson S.B., Coddngton C.C., Vella A. Ovarian stromal hyperthecosis: sonographic features and histologic associations. J Ultrasound Med 2009; 28: 587-593.
  4. Buggs C., Rosenfield R.L. Polycystic ovary syndrome in adolescence. Endocrinol Metabol Clin North Am 2005; 34: 677-705.
  5. Cordera F., Grant C., van Heerden J., Thompson G., Young W. Androgensecreting adrenal tumors. Surgery 2003; 134: 874-880.
  6. Davison S.L., Bell R., Donath S., Montalto J.G., Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metabol 2005; 90: 3847-3853.
  7. Diamanti-Kandarakis E., Lambrinoudaki I., Economou F. Androgens associated with advanced glycation end-products in postmenopausal women. Menopause 2010; 17: 1182-1187.
  8. Dorgan J.F., Stanczyk F.Z., Kahle L.L., Brinton L.A. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res 2011; 12: R98.
  9. Kaltsas G.A., Isidori A.M., Kola B.P. The value of the low-dosedexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metabol 2003; 88: 2634-2643.
  10. Katsiki N., Hatzitolios A.I. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update. Curr Opin Obstet Gynecol 2010; 22: 466-476.
  11. Klotz R.K., Muller-Holzner E., Fessler S. Leydig-celltumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature. Exp Clin Endocrinol Diabetol 2010; 118: 291-297.
  12. Krug E., Berga S.L. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary. Obstet Gynecol 2002; 99: 893-897.
  13. Martin K.A., Chang R.J., Ehrmann D.A., Ibanez L., Lobo R.A., Rosenfield R.L., Shapiro J., Montori V.N., Swiglo B.A. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabol 2008; 93: 1105-1120.
  14. Nieman L.K. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metabol 2010; 95: 4106-4113.
  15. Norman R.J.D., Legro R.S., Hickey T.E. Polycystic ovary syndrome. Lancet 2007; 370: 685-697.
  16. Rittmaster R.S. Polycystic ovary syndrome, hyperthecosis and the menopause. Clin Endocrinol (Oxford) 1997; 46: 129-130.
  17. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metabol 2007; 92: 405-413.
  18. Rothman M.S., Carlson N.E., Xu M. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids 2011; 76: 177-182.
  19. Rothman M.S., Wierman M.E. How should postmenopausal androgen excess be evaluated? Clin Endocrinol 2011; 75: 160-164.
  20. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
  21. Shaw L.J., Bairey Merz C.N., Azziz R., Stanczyk F.Z., Sopko G., Braunstein G.D., Kelsey S.F., Kip K.E., Cooper-Dehoff R.H., Johnson B.D., Vaccarino V., Reis S.E. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metabol 2008; 93: 1276-1284.
  22. Speiser P.W., Azziz R., Baskin L.S., Ghizzoni L., Hensle T.W., Merke D.B. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 2010; 95: 4133-4160.
  23. Thompson G.B., Young W.F.Jr. Adrenal incidentaloma. Curr Opin Oncol 2003; 15: 84-90.
  24. Waggoner W., Boots L.R., Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol 1999; 13: 394-400.
  25. Wild R.A., Carmina E., Diamanti-Kandarakis E., Dokras A., Escobar-Morreale H.F., Futterweit W., Lobo R., Norman R.J., Taibott E., Dumesic D.A. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metabol 2010; 95: 2038-2049.
  26. Winters S.J., Talbott E., Guzick D.S., Zborowsky J., McHugh K.P. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 2000; 73: 724-729.
  27. Yetkin D.O., Demirsoy E.T., Kadioglu P. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis. Gynecol Endocrinol 2011; 27: 237-240.
  28. Young W.F.Jr. Clinical practice. The incidentally discovered adrenal mass. New Engl J Med 2007; 356: 601-610.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.